The University of Chicago Header Logo

Connection

Tatjana Antic to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications Tatjana Antic has written about Biomarkers, Tumor.
Tatjana Antic
Connection Strength
7.959
Biomarkers, Tumor
  1. Comprehensive analysis of six MED15::TFE3 renal cell carcinomas including two novel solid MED15::TFE3 renal cell carcinomas, highlighting their morphologic, immunohistochemical and molecular differences from their cystic counterparts. Virchows Arch. 2026 Sep; 489(3):669-680.
    View in: PubMed
    Score: 0.503
  2. The Many Faces of TPM3::ALK Fusion Renal Cell Carcinoma: Case Report and Review of the Literature. Int J Surg Pathol. 2026 Aug; 34(5):1241-1246.
    View in: PubMed
    Score: 0.498
  3. MTOR-mutated eosinophilic renal cell carcinomas with loss of chromosome 1 and high metastatic potential: further expanding the spectrum of TSC/mTOR pathway mutated renal tumors. Virchows Arch. 2026 Sep; 489(3):575-581.
    View in: PubMed
    Score: 0.487
  4. Renal Tumorigenesis via RAS/RAF/MAPK Pathway Alterations Beyond Papillary Renal Neoplasm With Reverse Polarity. Am J Surg Pathol. 2025 Dec 01; 49(12):1266-1278.
    View in: PubMed
    Score: 0.473
  5. Primary Melanoma of the Lung: A Vanishing Entity. Acta Cytol. 2025; 69(4):361-366.
    View in: PubMed
    Score: 0.469
  6. Aggressive renal cell carcinoma with somatic BRCA2 mutation-an emerging entity? A case report with literature review. Virchows Arch. 2025 Aug; 487(2):471-476.
    View in: PubMed
    Score: 0.456
  7. GATA3 Expression in Solid Vimentin-Negative Eosinophilic Renal Epithelial Tumors-A Comprehensive Study of 48 Tumors. Int J Surg Pathol. 2025 Jun; 33(4):820-827.
    View in: PubMed
    Score: 0.453
  8. TSC/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+/CK20-/vimentin-: a validation study. Hum Pathol. 2021 09; 115:84-95.
    View in: PubMed
    Score: 0.346
  9. A Tale of 2 Morphologies: Diagnostic Pitfalls in TFEB-Associated Renal Cell Carcinomas, Including a Novel NEAT1-TFEB Fusion. Int J Surg Pathol. 2021 Feb; 29(1):21-29.
    View in: PubMed
    Score: 0.339
  10. Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous: Clinicopathologic and Molecular Study. Am J Surg Pathol. 2020 07; 44(7):943-954.
    View in: PubMed
    Score: 0.335
  11. Rhabdomyosarcoma of the Adult Prostate: A Case Report With Complete Molecular Profile. Int J Surg Pathol. 2020 Feb; 28(1):92-98.
    View in: PubMed
    Score: 0.315
  12. Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma. Am J Surg Pathol. 2019 08; 43(8):1135-1144.
    View in: PubMed
    Score: 0.314
  13. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates. Acta Cytol. 2019; 63(5):438-444.
    View in: PubMed
    Score: 0.312
  14. Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations? Am J Surg Pathol. 2018 07; 42(7):911-917.
    View in: PubMed
    Score: 0.292
  15. Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion. Am J Surg Pathol. 2017 Nov; 41(11):1576-1580.
    View in: PubMed
    Score: 0.278
  16. Primary epithelioid sarcoma of the kidney and adrenal gland: report of 2 cases with immunohistochemical and molecular cytogenetic studies. Hum Pathol. 2017 03; 61:158-163.
    View in: PubMed
    Score: 0.259
  17. Oncocytic epithelial-myoepithelial carcinoma: an evolving new variant with comparative immunohistochemistry. Pathology. 2008 Jun; 40(4):415-8.
    View in: PubMed
    Score: 0.145
  18. Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors. Hum Pathol. 2026 Sep; 175:106154.
    View in: PubMed
    Score: 0.126
  19. Cytomorphologic and molecular characterization of metastatic renal cell carcinoma diagnosed by fine-needle biopsy: a single-institution study. J Am Soc Cytopathol. 2026 May-Jun; 15(3):197-206.
    View in: PubMed
    Score: 0.124
  20. PAX8-positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles - A clinicopathologic study of 101 consecutive cases with next-generation sequencing in 20 cases. Histopathology. 2026 Jun; 88(7):1315-1323.
    View in: PubMed
    Score: 0.123
  21. Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features. Histopathology. 2026 Apr; 88(5):1044-1050.
    View in: PubMed
    Score: 0.122
  22. Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization. Cancer Med. 2024 01; 13(1):e6873.
    View in: PubMed
    Score: 0.107
  23. Oncocytoma-Like Angiomyolipoma of the Kidney: A Closer Look into the Clinicopathologic, Immunohistochemical, and Molecular Characteristics of a Rare Entity with Review of the Literature. Int J Surg Pathol. 2024 May; 32(3):625-631.
    View in: PubMed
    Score: 0.104
  24. TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases. Hum Pathol. 2023 04; 134:124-133.
    View in: PubMed
    Score: 0.100
  25. NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases. Am J Surg Pathol. 2022 05 01; 46(5):617-627.
    View in: PubMed
    Score: 0.095
  26. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling. Hum Pathol. 2020 10; 104:18-29.
    View in: PubMed
    Score: 0.084
  27. Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma. Virchows Arch. 2020 Mar; 476(3):383-390.
    View in: PubMed
    Score: 0.079
  28. Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression. Mod Pathol. 2018 04; 31(4):623-632.
    View in: PubMed
    Score: 0.070
  29. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics. Hum Pathol. 2017 08; 66:152-158.
    View in: PubMed
    Score: 0.068
  30. Benign müllerian glandular inclusions in men undergoing pelvic lymph node dissection. Hum Pathol. 2016 11; 57:136-139.
    View in: PubMed
    Score: 0.064
  31. MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer. J Magn Reson Imaging. 2015 Dec; 42(6):1733-9.
    View in: PubMed
    Score: 0.059
  32. Carbonic anhydrase IX (CAIX) does not differentiate between benign and malignant mesothelium. Am J Clin Pathol. 2014 Jul; 142(1):82-7.
    View in: PubMed
    Score: 0.055
  33. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Am J Surg Pathol. 2013 Dec; 37(12):1876-81.
    View in: PubMed
    Score: 0.053
  34. Diagnostic utility of CD10 in benign and malignant extrahepatic bile duct lesions. Am J Surg Pathol. 2012 Jan; 36(1):101-8.
    View in: PubMed
    Score: 0.046
  35. Mixed epithelial and stromal tumor of the kidney and cystic nephroma share overlapping features: reappraisal of 15 lesions. Arch Pathol Lab Med. 2006 Jan; 130(1):80-5.
    View in: PubMed
    Score: 0.031
  36. Inflammatory sarcomatoid carcinoma: a case report and discussion of a malignant tumor with benign appearance. Arch Pathol Lab Med. 2005 Oct; 129(10):1334-7.
    View in: PubMed
    Score: 0.030
  37. Metastatic renal cell carcinoma with fibromyomatous stroma associated with tuberous sclerosis or MTOR, TSC1/TSC2-Mutations: A Series of 4 cases and a review of the literature. Hum Pathol. 2024 Nov; 153:105680.
    View in: PubMed
    Score: 0.028
  38. Cytomorphologic and molecular characterization of spindle cell carcinoid tumors of the lung. Cancer Cytopathol. 2024 10; 132(10):656-665.
    View in: PubMed
    Score: 0.028
  39. Cytopathology and clinicopathological correlation of renal neuroendocrine neoplasms. J Am Soc Cytopathol. 2024 Nov-Dec; 13(6):406-412.
    View in: PubMed
    Score: 0.028
  40. Solid pseudopapillary neoplasm (SPN) of the testis: Comprehensive mutational analysis of 6 testicular and 8 pancreatic SPNs. Ann Diagn Pathol. 2018 Aug; 35:42-47.
    View in: PubMed
    Score: 0.018
  41. Primary signet ring stromal tumor of the testis: a study of 13 cases indicating their phenotypic and genotypic analogy to pancreatic solid pseudopapillary neoplasm. Hum Pathol. 2017 09; 67:85-93.
    View in: PubMed
    Score: 0.017
  42. Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer. AJR Am J Roentgenol. 2013 Nov; 201(5):1041-8.
    View in: PubMed
    Score: 0.013
  43. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. Hum Pathol. 2013 Apr; 44(4):495-502.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.